Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Lampl, C; Likar, R.
[Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
Schmerz. 2014; 28(6): 584-90.
Doi: 10.1007/s00482-014-1490-7
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Likar Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Metamizole (dipyrone) is a nonsteroidal compound with strong analgesic as well as antipyretic and spasmolytic properties. Based on a small number of cases of agranulocytosis, metamizole was withdrawn from the market in some countries. Other countries restricted its use. This paper discusses the safety aspects of metamizole and compares it with other compounds used for similar indications.
- Find related publications in this database (using NLM MeSH Indexing)
- Agranulocytosis - chemically induced
- Anti-Inflammatory Agents, Non-Steroidal - adverse effects, therapeutic use
- Dipyrone - adverse effects, therapeutic use
- Drug Interactions - administration & dosage
- Humans - administration & dosage
- Risk - administration & dosage
- Safety-Based Drug Withdrawals - administration & dosage
- Find related publications in this database (Keywords)
- Analgesia
- Antipyretic effect
- Safety
- Mode of action
- Adverse effects